 The primary objective of this study is to compare the efficacy, safety, and tolerability of tenofovir alafenamide TAF versus tenofovir disoproxil fumarate TDF in treatment-naive and treatment-experienced adults with hepatitis B e antigen HBeAg-positive chronic hepatitis B virus HBV infection. 